Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ultimovacs A/S
DescriptionVaccine consisting of three human telomerase reverse transcriptase (hTERT) peptide epitopes plus the immunostimulatory adjuvant granulocyte macrophage colony-stimulating factor (GM-CSF; CSF2)
Molecular Target Telomerase reverse transcriptase (TERT)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today